Case Study
Cardiology
Our cardiology-focused research helps clients explore the potential of their cardiovascular products by analyzing current treatment patterns, physician attitudes, and patient outcomes. We offer a detailed understanding of the cardiovascular therapeutic landscape, pinpointing opportunities for growth and innovation. Our approach ensures cardiology products align with market needs and regulatory guidelines, positioning them effectively for success.
ATU Tracker in 5 TAs: Cardiology, Gastroenterology, Nephrology, Women’s Health & Patient Blood Management
Objective of the Study
Tracking of brand health over time (KPIs). Focus on management of Heart Failure, GI disorders, pregnant or postpartum or heavy bleeding, chronic kidney disease patients with iron deficiency anaemia. Brand positioning among competitors + mini segmentation included.
Methodology
METHODOLOGY
Online questionnaire with patient records – 20/25 minutes:
Wave 1 – 6 Countries
Wave 2 – 20 Countries
Wave 3 – 17 Countries
Wave 4 – 23 Countries
Wave 5 – 25 countries
GEOGRAPHICAL SCOPE:
Argentina, Australia, Belgium, Brazil, Canada, China, Denmark, France, Germany, Netherlands, Ireland, Italy, Japan, Korea, Mexico, Peru, Portugal, Romania, Russia, Saudi Arabia, Spain, UK, Turkey, USA, Poland
SAMPLE
Cardiologists
Gastroenterologists
Nephrologists
Gynecologists
Hematologists
Surgeons
Anesthesiologists
MAIN RESULTS
Provided understanding of the treatment of iron deficiency anemia, the most important key factors in the diagnosis algorithm (comorbidities, patient pathway, tests used for diagnostic, thresholds and therapy goals values) and also the therapy selection process (oral vs IV products).
Evaluated aided and unaided awareness, experience with different products (trial and usage, NPS, brand loyalty), current and future share by products and preferences linked to different evaluated criteria (gaps analysis).
Analysed competitor products and showed the client in what areas they should improve communication on their product and also in what areas they should maintain or decrease efforts (importance vs. relevance).
KEY TAKE-AWAY
Provided country specific insights related to diagnosis, treatment and brand choice with direct implications for business activity in order to position the treatment.
Provided recommendations on how to achieve a strong brand positioning by improving the communication strategy and highlighting the aspects which are important for physicians – list of attributes was defined per country and tracker.
Congress research
Objective of the Study
Recall test for client’s symposium on treatment of amyloidosis and 2 other competitor symposiums on the HCPs who attended symposiums on amyloidosis at the 2019 Heart Failure Congress in Athens.
Methodology
METHODOLOGY
Corridor survey with questionnaire focused on key topics, prepared in English.
Questionnaires done on iPad which uploaded the answers onto a secured platform.
GEOGRAPHICAL SCOPE: Europe, Asia, EMEA, LATAM, Canada, US.
SAMPLE
113 cardiologists
LOI = 5-8 minutes each. Number of key questions: approx. 10
MAIN RESULTS
Analyzed attendance for all 3 symposiums.
Evaluated awareness, level of interest and spontaneous information recall.
Measured impact on prescription by the HCPs in attendance.
KEY TAKE-AWAY
Provided a detailed view on the profile of HCPs and most prevalent type of amyloidosis patients among physicians in attendance.
Identified the main take-aways and Information perceived as new by the HCPs.